Eosinophilic panniculitis associated with COVID-19

Within just 3 months of the detection in Wuhan in December 2019 of the first cases of pneumonia caused by a novel coronavirus, the scale of this outbreak has increased to pandemic proportions. As the number of cases increased, new respiratory, neurological, digestive, and dermatological clinical manifestations were also reported.1 A 29-year-old Colombian woman with no relevant history was seen at our emergency department for skin lesions that had appeared 1 week earlier. She had cough and fever that had begun 20 days earlier and for which she was not being treated. She reported no dyspnea and her baseline oxygen saturation was 97%. A laboratory workup revealed the following: D-dimer, 1 790.0 ng/mL; lymphocytes, 1 500/µL; lactate dehydrogenase, 202 U/L; C-reactive protein < 0.5 mg/L. Chest x-ray was normal. Polymerase chain reaction analysis of a pharyngeal swab was positive for SARS-CoV-2.

• Tipo de recurso: Article of investigation
• Fecha de publicación: 2020
• Institución: Universidad de Bogotá Jorge Tadeo Lozano
• Repositorio: Expeditio: repositorio UTadeo
• Idioma: eng
• OAI Identifier: oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14565
• Acceso en línea: https://doi.org/10.1016/j.adengl.2020.10.003; http://hdl.handle.net/20.500.12010/14565
• Palabra clave: Eosinophilic panniculitis; COVID-19; Síndrome respiratorio agudo grave; COVID-19; SARS-CoV-2; Coronavirus
• License: Abierto (Texto Completo)